Sirnaomics (02257)
Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People’s Republic of Chin...
- Open
- 3.800
- High
- 3.950
- Low
- 3.750
- Prev. Close
- 3.900
- Volume
- 95.70K
- Turnover
- 364.78K
- Avg Price
- 3.812
- Bid/Ask Ratio
- 11.86%
- Amplitude
- 5.13%
- 52wk High
- 22.780
- Volume Ratio
- 1.42
- Turnover Ratio
- 0.09%
Sirnaomics Analyst Rating
View moreForecast & Rating
Jun 3, 2026Price forecast
HK$72.111765.60%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 1 day ago, 05:13 AM
The Liquidity Bifurcation in Hong Kong: From Crypto Inverse Products to Micro-Cap Anomalies
- PUBT · Aug 14 at 08:01 AM
Sirnaomics sues former executives over US$20 million TradArt investment
- PUBT · Aug 14 at 04:02 AM
Sirnaomics schedules board meeting to review interim results
- PUBT · Aug 12 at 04:01 AM
Sirnaomics completes placement of 2,435,600 shares at HK$4.69 each, raising HK$11.3 million net
- Global Report · Aug 11 at 05:13 AM
Medical and Hardware Rebound Signals Profit Reversals in Unclassified Hong Kong Equities
- PUBT · Jul 30 at 04:17 AM
Sirnaomics completes first patient dosing in Phase II trial of STP705 for medical aesthetics
